Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinsuke Yasuda

Showing results (121-130 of 153) with videos related to

Pageof 16
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|October 27, 2017
Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder: Do They Share Common Targets?Simone Mader, Venkatesh Jeganathan, Yoshiyuki Arinuma, et al.
Immunological Medicine|May 15, 2024
ARID5B is a negative modulator of IL-6 production in rheumatoid arthritis synovial fibroblastsYasuhiro Tagawa, Tetsuya Saito, Hideyuki Iwai, et al.
Nature Plants|December 23, 2016
A complex dominance hierarchy is controlled by polymorphism of small RNAs and their targetsShinsuke Yasuda, Yuko Wada, Tomohiro Kakizaki, et al.
The Journal of Rheumatology|May 19, 2009
Immunological reconstitution after autologous hematopoietic stem cell transplantation in patients with systemic sclerosis: relationship between clinical benefits and intensity of immunosuppressionToshiyuki Bohgaki, Tatsuya Atsumi, Miyuki Bohgaki, et al.
Frontiers in Immunology|November 1, 2023
Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matchingSeiya Oba, Tadashi Hosoya, Risa Kaneshige, et al.
Rheumatology (Oxford, England)|February 21, 2016
Ribophorin II is involved in the tissue factor expression mediated by phosphatidylserine-dependent antiprothrombin antibody on monocytesYuichiro Fujieda, Olga Amengual, Masaki Matsumoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 7, 2021
Predictors associated with clinical improvement of SARS-CoV-2 pneumoniaTakahiro Mitsumura, Tsukasa Okamoto, Tsuyoshi Shirai, et al.
Modern Rheumatology|July 29, 2015
A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in JapanRyoki Hara, Hirotaka Miyazawa, Kenichi Nishimura, et al.
Modern Rheumatology|December 15, 2017
Clinical significance of plasma presepsin levels in patients with systemic lupus erythematosusShun Tanimura, Yuichiro Fujieda, Michihiro Kono, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 7, 2024
Real-world experience of tixagevimab/cilgavimab prophylaxis in Japanese patients with immunodeficiencyKento Inoue, Dan Tomomasa, Yu Nakagama, et al.
Pageof 16

Showing results (121-130 of 153) with videos related to

Sort By:
Pageof 16
Arthritis & Rheumatology (Hoboken, N.J.)|October 27, 2017
Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder: Do They Share Common Targets?Simone Mader, Venkatesh Jeganathan, Yoshiyuki Arinuma, et al.
Immunological Medicine|May 15, 2024
ARID5B is a negative modulator of IL-6 production in rheumatoid arthritis synovial fibroblastsYasuhiro Tagawa, Tetsuya Saito, Hideyuki Iwai, et al.
Nature Plants|December 23, 2016
A complex dominance hierarchy is controlled by polymorphism of small RNAs and their targetsShinsuke Yasuda, Yuko Wada, Tomohiro Kakizaki, et al.
The Journal of Rheumatology|May 19, 2009
Immunological reconstitution after autologous hematopoietic stem cell transplantation in patients with systemic sclerosis: relationship between clinical benefits and intensity of immunosuppressionToshiyuki Bohgaki, Tatsuya Atsumi, Miyuki Bohgaki, et al.
Frontiers in Immunology|November 1, 2023
Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matchingSeiya Oba, Tadashi Hosoya, Risa Kaneshige, et al.
Rheumatology (Oxford, England)|February 21, 2016
Ribophorin II is involved in the tissue factor expression mediated by phosphatidylserine-dependent antiprothrombin antibody on monocytesYuichiro Fujieda, Olga Amengual, Masaki Matsumoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 7, 2021
Predictors associated with clinical improvement of SARS-CoV-2 pneumoniaTakahiro Mitsumura, Tsukasa Okamoto, Tsuyoshi Shirai, et al.
Modern Rheumatology|July 29, 2015
A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in JapanRyoki Hara, Hirotaka Miyazawa, Kenichi Nishimura, et al.
Modern Rheumatology|December 15, 2017
Clinical significance of plasma presepsin levels in patients with systemic lupus erythematosusShun Tanimura, Yuichiro Fujieda, Michihiro Kono, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 7, 2024
Real-world experience of tixagevimab/cilgavimab prophylaxis in Japanese patients with immunodeficiencyKento Inoue, Dan Tomomasa, Yu Nakagama, et al.
Pageof 16